Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Mark Didmon has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11760819

COMBINED USE OF FC GAMMA RIIB (CD32B) AND CD20 - SPECIFIC ANTIBODIES

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/28
Applicant:
University of Southampton
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
GRANT OF PATENT INTENDED
EP11740483

BIOMINERAL AND METAL BINDING LIPOSOMES, THEIR SYNTHESIS, AND METHODS OF USE THEREOF

IPC classification:
A61K 9/127, A61K 47/48, A61K 51/00, A61P 19/08
Applicant:
The Board of Regents of the University of Nebraska
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11755433

SELF-ADJUSTING BRA STRAP

IPC classification:
A41C 3/00, A41F 15/00
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731575

METHODS FOR IN SITU DETECTION OF NUCLEOTIDE SEQUENCES

IPC classification:
C12Q 1/68
Agent:
Mark Didmon, Potter Clarkson LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature